Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Sciences

Radiopharmaceutical Treatment of Malignant Pheochromocytoma

James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee and Donald M. Wieland
Journal of Nuclear Medicine February 1984, 25 (2) 197-206;
James C. Sisson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brahm Shapiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William H. Beierwaltes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry V. Glowniak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Nakajo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. Mangner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Carey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis P. Swanson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean E. Copp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winston G. Satterlee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald M. Wieland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 25, Issue 2
February 1, 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee, Donald M. Wieland
Journal of Nuclear Medicine Feb 1984, 25 (2) 197-206;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee, Donald M. Wieland
Journal of Nuclear Medicine Feb 1984, 25 (2) 197-206;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • ScRNA-seq of Diverse Pheochromocytoma Patients Reveals Distinct Microenvironment Characteristics and Supports an Informative Molecular Classification System
  • Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors
  • Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
  • Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas
  • Extended stability of iobenguane under simulated clinical conditions
  • Google Scholar

More in this TOC Section

Clinical Sciences

  • Can Quantitative Renography Predict the Outcome of Treatment of Atherosclerotic Renal Artery Stenosis?
  • Estimation of Technetium-99m-MAG3 Plasma Clearance in Adults from One or Two Blood Samples
  • Nonimmunogenic Hyperthyroidism: Cumulative Hypothyroidism Incidence After Radioiodine and Surgical Treatment
Show more Clinical Sciences

Therapeutic Nuclear Medicine

  • Serum Thyroglobulin, A Monitor of Differentiated Thyroid Carcinoma in Patients Receiving Thyroid Hormone Suppression Therapy: Concise Communication
  • Pure Follicular Thyroid Carcinoma: Impact of Therapy in 214 Patients
Show more Therapeutic Nuclear Medicine

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire